FHIR © HL7.org  |  FHIRsmith 4.0.1  |  Server Home  |  XIG Home  |  XIG Stats  | 

FHIR IG analytics

Packagehl7.fhir.us.mcode.r4
Resource TypeMedicationRequest
IdMedicationRequest-cancer-related-medication-request-gefitinib.json
FHIR VersionR4

Resources that use this resource

No resources found


Resources that this resource uses

No resources found


Narrative

Note: links and images are rebased to the (stated) source

Generated Narrative: MedicationRequest cancer-related-medication-request-gefitinib

Procedure Intent Extension: Curative - procedure intent

Normalization Basis Extension: Body surface area (observable entity)

status: Active

intent: Order

medication: gefitinib 250 MG Oral Tablet

subject: John B. Anyperson Male, DoB: 1951-01-20 ( Medical Record Number: m123 (use: usual, ))

authoredOn: 2019-04-01

requester: Practitioner Kyle Anydoc

reasonCode: Non-small cell lung cancer (disorder)

dosageInstruction

text: 250mg orally once daily with or without food

timing: Code , Events: 2019-04-01 , Once per 1 day

route: Oral use

DoseAndRates

-Dose[x]
*250 mg (Details: UCUM codemg = 'mg')

Source1

{
  "resourceType": "MedicationRequest",
  "id": "cancer-related-medication-request-gefitinib",
  "meta": {
    "profile": [
      "http://hl7.org/fhir/us/mcode/StructureDefinition/mcode-cancer-related-medication-request"
    ]
  },
  "text": {
    "status": "extensions",
    "div": "<!-- snip (see above) -->"
  },
  "extension": [
    {
      "url": "http://hl7.org/fhir/us/mcode/StructureDefinition/mcode-procedure-intent",
      "valueCodeableConcept": {
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "373808002",
            "display": "Curative - procedure intent"
          }
        ]
      }
    },
    {
      "url": "http://hl7.org/fhir/us/mcode/StructureDefinition/mcode-normalization-basis",
      "valueCodeableConcept": {
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "301898006",
            "display": "Body surface area (observable entity)"
          }
        ]
      }
    }
  ],
  "status": "active",
  "intent": "order",
  "medicationCodeableConcept": {
    "coding": [
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "code": "349472",
        "display": "gefitinib 250 MG Oral Tablet"
      }
    ]
  },
  "subject": {
    "reference": "Patient/cancer-patient-john-anyperson"
  },
  "authoredOn": "2019-04-01",
  "requester": {
    "reference": "Practitioner/us-core-practitioner-kyle-anydoc"
  },
  "reasonCode": [
    {
      "coding": [
        {
          "system": "http://snomed.info/sct",
          "code": "254637007",
          "display": "Non-small cell lung cancer (disorder)"
        }
      ]
    }
  ],
  "dosageInstruction": [
    {
      "text": "250mg orally once daily with or without food",
      "timing": {
        "event": [
          "2019-04-01"
        ],
        "repeat": {
          "boundsPeriod": {
            "start": "2019-04-30"
          },
          "frequency": 1,
          "period": 1,
          "periodUnit": "d"
        },
        "code": {
          "coding": [
            {
              "system": "http://terminology.hl7.org/CodeSystem/v3-GTSAbbreviation",
              "code": "QD"
            }
          ]
        }
      },
      "route": {
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "26643006",
            "display": "Oral use"
          }
        ]
      },
      "doseAndRate": [
        {
          "doseQuantity": {
            "value": 250,
            "unit": "mg",
            "system": "http://unitsofmeasure.org",
            "code": "mg"
          }
        }
      ]
    }
  ]
}